Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls With Precocious Puberty and McCune-Albright Syndrome (MAS)

NCT00006174 is registered in ClinicalTrials.gov with National Institute of Dental and Craniofacial Research (NIDCR) as lead sponsor.

NCT NCT00006174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls With Precocious Puberty and McCune-Albright Syndrome (MAS)
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Phase
Phase 1
Overall status
Completed
Start date
August 3, 2000
Completion date
May 18, 2009
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mccune albright syndrome, polyostotic fibrous dysplasia, precocious puberty